|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/401 | |
| A61K 31/7004 | |||
| A61K 31/7008 | |||
| A61K 45/06 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2252289 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09701670.3 |
| Europos patento paraiškos padavimo data | 2009-01-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-11-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2009/051023 |
| Data | 2009-01-16 |
| (87) | Numeris | WO 2009/091082 |
| Data | 2009-07-23 |
| (30) | Numeris | Data | Šalis |
| 2177708 P | 2008-01-17 | US |
| (72) |
UETA, Kiichiro, JP
ARAKAWA, Kenji, JP
MATSUSHITA, Yasuaki, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505,
JP
|
| (54) | COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS |
| COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS |